FDA Announces New Nationwide Blood Pressure Medication Recall
The FDA has initiated a nationwide recall of over 13,000 bottles of the blood pressure medication chlorthalidone due to quality control failures.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
The FDA issued a nationwide recall for more than 13,000 bottles of the blood pressure medication chlorthalidone. The recall followed a quality issue where the drug failed dissolution specifications and was given a Class II designation.
Epilogue added 47d ago, after coverage quieted.
The brief
Food and Drug Administration has announced a nationwide recall involving the blood pressure medication chlorthalidone. According to reporting from Dallas News, more than 13,000 bottles of the medication are affected by this action. The recall is a response to a specific quality issue identified within the drug supply. News4JAX and USA Today confirm that the scope of this recall is national, impacting thousands of bottles across the United States. The action aims to remove the compromised medication from the market to ensure patient safety and drug efficacy. Coverage from several outlets emphasizes the technical nature of the failure and the regulatory status of the recall.
Additionally, NewsNation reports that the recall has been given a Class II designation in a recent update. These details indicate that the FDA is treating the dissolution failure as a significant quality concern. The reports from Newsday further identify the specific drug involved as chlorthalidone, a medication commonly used to manage hypertension. Context for this event is rooted in the strict quality standards the FDA requires for pharmaceutical stability and performance. The failure of 'dissolution specifications' mentioned by FOX 9 Minneapolis-St. For patients relying on blood pressure medication, consistency in drug delivery is critical for managing cardiovascular health.
The Class II designation mentioned by NewsNation suggests a level of risk where use of the product may cause temporary or medically reversible adverse health consequences. Looking forward, the coverage suggests that patients should check their medications to see if they are among the affected lots. USA Today has urged consumers to see which specific drugs are affected by the nationwide recall. While the FDA has already issued the recall notice, the focus now remains on the recovery of the 13,000 bottles mentioned by Dallas News. Future updates will likely track whether the drug company implements new quality controls to prevent further dissolution failures or if the scope of the recall expands beyond the current bottle count.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (89% supported) Updated 49d ago.
Quick answers
How many bottles of medication are being recalled?
According to the Dallas News, more than 13,000 bottles are affected.
What is the name of the recalled medication?
The medication being recalled is the blood pressure drug chlorthalidone.
Why was the medication recalled?
FOX 9 Minneapolis-St. Paul reports that the drug failed 'dissolution specifications.'
Coverage (8)
- Widely used blood pressure medication recalled nationwide Fox Business · 49d ago
- FDA recalls more than 13,000 bottles of blood pressure medication after quality issue Dallas News · 50d ago
- Drug company recalls blood pressure medication chlorthalidone Newsday · 50d ago
- Blood pressure medication given Class II designation in recall update NewsNation · 50d ago
- Thousands of bottles of blood pressure medication recalled nationwide News4JAX · 50d ago
- Blood pressure medication recalled nationwide. See affected drug USA Today · 50d ago
- Blood pressure medication recalled nationwide after failing 'dissolution specifications' FOX 9 Minneapolis-St. Paul · 50d ago
- FDA Announces New Nationwide Blood Pressure Medication Recall AOL.com · 51d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
More people are getting the flu. Should you get a flu shot before you travel?
Multiple U.S. outlets publish coordinated flu-shot guidance as seasonal influenza activity rises ahead of holiday travel.
Possible measles case in North Carolina child prompts public exposure warning
North Carolina health officials investigate a possible measles case in a Catawba County child while warning of public exposures at a Hickory church and pediatric clinic.
The Virus That Makes Your Immune System Forget
Measles remains a highly contagious and potentially deadly disease, with an estimated 95,000 deaths in 2024, mostly children under five, despite a safe and inexpensive vaccine.
CDC declined to alert risk of measles in pregnancy. A journal released the data.
CDC withheld pregnancy measles risk alert while a medical journal published data showing at least 167 infected pregnant Americans since 2025.
US braces for loss of measles elimination status amid worst outbreak in decades
The United States has officially lost its measles elimination status after a 26-year run, marking a historic setback for American public health as outbreaks surge nationwide.